Skip to content

Study · Case report or series · n = 1 · 2000

4 results

Use of a long-acting gonadotrophin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour.

Picón MJ, Lara JI, Sarasa JL, Recasens JD, Clouet R, Gonzalo MA, Rovira A

European journal of endocrinology1 Jun 2000Cited by 17 (Europe PMC)

PMID10822225 (opens in a new tab)DOI10.1530/eje.0.1420619 (opens in a new tab)PepBankPUB-10822225
Source linkPubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a postmenopausal woman with a hilus cell tumour, triptorelin reduced serum testosterone to normal values.

    In plain wordsIn a postmenopausal woman, triptorelin reduced testosterone to normal levels.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    DecreaseSerum testosterone
    Study

    n = 1

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    3.75 mg · intramuscularAs given in this study (human).

    Source sentences

    Summary
    GnRH produced a decrease in serum testosterone levels to normal values, in parallel with the suppression of serum LH and FSH concentrations.
    2 context sentences
    Summary · context
    We present a case of a 72-year-old woman with virilization of recent onset.
    Summary · context
    The long-acting GnRH analogue, triptorelin, was injected initially (3.75mg i.m.) and serum hormone levels were measured weekly throughout one month.
  2. 02HumanCase report or seriesEfficacy outcome

    In a postmenopausal woman with a hilus cell tumour, triptorelin suppressed serum LH.

    In plain wordsIn a postmenopausal woman, triptorelin reduced LH levels.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    DecreaseSerum LH
    Study

    n = 1

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    3.75 mg · intramuscularAs given in this study (human).

    Source sentences

    Summary
    GnRH produced a decrease in serum testosterone levels to normal values, in parallel with the suppression of serum LH and FSH concentrations.
    2 context sentences
    Summary · context
    We present a case of a 72-year-old woman with virilization of recent onset.
    Summary · context
    The long-acting GnRH analogue, triptorelin, was injected initially (3.75mg i.m.) and serum hormone levels were measured weekly throughout one month.
  3. 03HumanCase report or seriesEfficacy outcome

    In a postmenopausal woman with a hilus cell tumour, triptorelin suppressed serum FSH.

    In plain wordsIn a postmenopausal woman, triptorelin reduced FSH levels.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    DecreaseSerum FSH
    Study

    n = 1

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    3.75 mg · intramuscularAs given in this study (human).

    Source sentences

    Summary
    GnRH produced a decrease in serum testosterone levels to normal values, in parallel with the suppression of serum LH and FSH concentrations.
    2 context sentences
    Summary · context
    We present a case of a 72-year-old woman with virilization of recent onset.
    Summary · context
    The long-acting GnRH analogue, triptorelin, was injected initially (3.75mg i.m.) and serum hormone levels were measured weekly throughout one month.
  4. 04HumanCase report or seriesEfficacy outcome

    In a postmenopausal woman, hyperandrogenic symptoms improved during triptorelin treatment.

    In plain wordsIn a postmenopausal woman, symptoms of excess androgen improved during triptorelin treatment.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    DecreaseHyperandrogenic symptoms
    Study

    n = 1

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    3.75 mg · intramuscular · three monthsAs given in this study (human).

    Source sentences

    Summary
    The patient was treated for three months with triptorelin and she experienced an amelioration of the hyperandrogenic symptoms.
    2 context sentences
    Summary · context
    We present a case of a 72-year-old woman with virilization of recent onset.
    Summary · context
    The long-acting GnRH analogue, triptorelin, was injected initially (3.75mg i.m.) and serum hormone levels were measured weekly throughout one month.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.